Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakano, S.
Right arrow Articles by Kimura, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakano, S.
Right arrow Articles by Kimura, J.
Related Collections
Right arrow All Neuromuscular Disease
Right arrow Muscle disease
Neurology 2001;56:87-93
© 2001 American Academy of Neurology
Articles

Inclusion body myositis

Expression of extracellular signal-regulated kinase and its substrate

S. Nakano, MD, PhD;, A. Shinde, MD;, S. Kawashima, MD, PhD;, S. Nakamura, MD, PhD;, I. Akiguchi, MD, PhD; and J. Kimura, MD.

From the Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Address correspondence to Dr. Satoshi Nakano, Department of Neurology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawara-cho, Sakyo-ku Kyoto 606-8507 Japan; e-mail: snakano{at}isola.kuhp.kyoto-u.ac.jp


   Article Abstract
Top.
 Article Abstract
Introduction
 Materials and methods.
 Results.
 Discussion.
 References
 
Objective: To assess abnormal intracellular signal transduction in inclusion body myositis (IBM). Background: Mitogen-activated protein kinases (MAPKs) play pivotal roles in intracellular signal transduction and regulate cell growth and differentiation. Upon their activation, MAPKs translocate from the cytoplasm into the nucleus. Design/methods: The authors investigated the localization of several forms of the MAPK family—extracellular signal-regulated kinase (ERK), c-Jun N-terminal protein kinase (JNK), and p38 MAPK (p38)—in 10 patients with sporadic IBM and in 52 control subjects. The relationship between the localization of immunopositive deposits and nuclei was tested with bis-benzimide. Results: Vacuolated fibers in IBM displayed very strong focal immunoreactivity of ERK, but not of JNK or p38. The ERK-positive deposits in these vacuolated fibers colocalized with the nuclear substrate of ERK, Elk-1. ERK- and Elk-1–positive deposits were located frequently on the surface of the nuclei in vacuolated fibers in IBM. Similar findings to those of sporadic IBM were observed in three patients with distal myopathy with rimmed vacuoles, but not in eight normal or the other 41 disease controls. Conclusion: There is evidence for impaired molecular transport to the nucleus from the cytoplasm in the vacuolated fibers in IBM. This could be due to cytoplasmic aggregation of ERK and Elk-1 or to abnormal nuclear pore machinery involved in the transport of ERK and its substrate upon ERK activation.


   Introduction
Top.
 Article Abstract
 Introduction
Materials and methods.
 Results.
 Discussion.
 References
 
Sporadic inclusion body myositis (s-IBM) is the most common muscle disease in patients older than 50 years. In addition to primary endomysial inflammation, muscle biopsies show vacuolated muscle fibers containing tubulofilaments in the cytoplasm and nuclei. Conversely, hereditary inclusion body myopathy (h-IBM) encompasses hereditary progressive muscle diseases with a pathologic process similar to that of s-IBM, except for a lack of lymphocytic inflammation.1,2 It includes myopathy with autosomal dominant inheritance of predominantly proximal weakness and autosomal recessive quadriceps-sparing myopathy.1 Distal myopathy with rimmed vacuoles, which is frequently observed in Japan, and the autosomal recessive h-IBM may be allelic or may be the same disorder.3,4

The vacuolated fibers in IBM express a variety of proteins that are expressed normally at the neuromuscular junction and lesions in neurodegenerative diseases.5 The ectopic expression of such proteins should result from abnormal intracellular events and altered transcription in IBM. Because protein kinases play pivotal roles in regulating intracellular signal transduction and transcription,6,7 studies of protein kinases in IBM may help to clarify the changes of protein expression in this disease. Accumulation of phosphorylated protein, which is immunoreactive for an antibody directed against phosphorylated neurofilament proteins (SMI-31) in vacuolated fibers in IBM,8 could indicate abnormal intracellular signal transduction.9

Extracellular signal-regulated kinase (ERK) belongs to the mitogen-activated protein kinase (MAPK) family, and plays a central role in transducing extracellular signals to the nucleus. After attachment to their receptors, hormones, growth factors, and cytokines evoke several intracellular signal transduction cascades, thereby regulating transcription in the nucleus.6,10 In one of the major branches of the cascades, these external stimuli induce tyrosine kinase activity at the cell surface and transient formation of Ras-guanosine 5' triphosphate (GTP). This in turn activates Raf kinase at the membrane, followed by sequential phosphorylation and activation of MAPK/ERK kinase (MEK) and ERK. Activated ERK phosphorylates various cytoplasmic molecules and translocates into the nucleus to phosphorylate a transcription factor called Elk-1.6,10 The activated form of Elk-1, together with serum response factor (SRF), binds to the serum response element (SRE) of the promoter region of immediate early genes, including c-fos ( figure 1A). 11 Conversely, environmental stresses and proinflammatory cytokines induce other phosphorylation cascades. In these stress-activated cascades, p38 MAPK (p38) and c-Jun N-terminal protein kinase (JNK), two subclasses of the MAPK family, take the equivalent position to ERK in the ERK cascade (see figure 1B).10,12 These complicated phosphorylation systems provide for a finely tuned, rapid regulation of signals at each level of the cascade, with cross-talk with other intracellular transduction cascades.



View larger version (21K):
[in this window]
[in a new window]
  		Figure 1. Schematic diagram of the (A) extracellular signal-regulated kinase (ERK) pathway and the (B) stress-activated mitogen-activated protein kinase (MAPK) pathways. MEK = MAPK or ERK kinase; Elk-1 = the nuclear substrate of ERK; SRF = serum response factor; SRE = serum response element; MEKKs = MEK kinases; MKK3,6 = MAPK kinase; JNK = c-Jun N-terminal protein kinase; p38 = p38 MAPK; SEK-1 = SAPK/ERK kinase-1. For details, see references 10 and 12.

 
We previously reported abnormal focal accumulation of CDK5 in vacuolated fibers in IBM.9 Like CDK5, MAPKs belong to the family of proline-directed protein kinases, which phosphorylate serine or threonine followed by proline in the amino acid sequences of substrate proteins. Furthermore, like CDK5, ERK translocates into the nucleus and positively regulates muscle fiber differentiation.13,14 These observations prompted us to examine the localization of ERK and its association with the nucleus in vacuolated fibers in IBM.


   Materials and methods.
Top.
 Article Abstract
 Introduction
 Materials and methods.
Results.
 Discussion.
 References
 
Patients. Limb muscle specimens from 10 patients (aged 43 to 76 years; nine men, one woman) with sporadic IBM were studied. Each muscle specimen contained endomysial inflammatory cell exudates, rimmed vacuoles, and congophilic inclusions. Therefore, the diagnosis of each patient was definite IBM.1 Four patients with oculopharyngeal muscular dystrophy (OPMD), three with distal myopathy with rimmed vacuoles, one with colchicine myopathy,15 and one with acid maltase deficiency were studied as non-IBM vacuolar myopathies. Eight muscle specimens deemed free of neuromuscular disease were used as normal controls. Fourteen patients with polymyositis, eight with dermatomyositis, five with Duchenne muscular dystrophy, four with mitochondrial myopathy, and four with neurogenic muscular atrophy served as other disease controls. The diagnoses were based on conventional criteria.16 Regenerating fibers were determined by examination of serial hematoxylin–eosin (H-E) sections.17

Primary antibodies. The table lists the characteristics of the primary antibodies against ERK and other subclasses of MAPKs and against transcription factors used in this study, and the concentrations at which they were applied. The anti-ERK antibody reacts with ERK1 and ERK2.18 The anti-JNK antibody binds to JNK1 and other isoforms of JNK.19 The anti–Elk-1 antibody has been well characterized.20 SMI-31 was obtained from Sternberger Monoclonals (Baltimore, MD) and used at 1,000-fold dilution.


View this table:
[in this window]
[in a new window]
  		Table 1. Primary antibodies against mitogen-activated protein kinases (MAPKs) and transcription factors
 
Immunostaining. Consecutive or nonconsecutive 7-µm transverse cryostat sections were fixed in cold acetone and incubated first in phosphate-buffered saline (PBS) containing 2% bovine serum albumin and 5% nonimmune serum from the species in which the secondary antibody was raised. Second, the sections were incubated overnight at 4 °C in the blocking solution containing the primary antibody. After incubation with a biotin-labeled second antibody, the sections were developed by the avidin–biotin complex (ABC) immunoperoxidase method (Vectastain ABC kit, Vector, Burlingame, CA). For double fluorescence staining, the sections were treated with 1) anti-ERK antibody and anti–Elk-1 antibody or 2) SMI-31 and anti–Elk-1 antibody at 4 °C overnight, followed by incubation with second antibodies consisting of rhodamine-conjugated goat antimouse immunoglobulin G (IgG) (Protos Immunoresearch, San Francisco, CA) and fluorescein isothiocyanate conjugated (FITC)-labeled swine antirabbit IgG (Dako, Carpinteria, CA). The slides were mounted with Vectashield (Vector), and viewed with an Olympus photomicroscope (Tokyo, Japan) equipped for epifluorescence.

Control experiments included omission of the primary antibody as well as substitution of nonimmune rabbit or mouse IgG in place of the primary antibody.

To assess the relationship of ERK- and Elk-1–positive deposits with nuclei, the immunostained sections were further stained with 1 µg/mL Hoechst 33258 (Molecular Probes, Eugene, OR), a DNA-binding dye. The mounted sections were examined under fluorescent microscopy.9


   Results.
Top.
 Article Abstract
 Introduction
 Materials and methods.
 Results.
Discussion.
 References
 
Localization of MAPKs and Elk-1 in s-IBM. In s-IBM, 60 to 96% of vacuolated fibers displayed very strong vacuolar and cytoplasmic immunoreactivity of ERK ( figure 2, A, C, and E). The ERK-positive deposits were round or irregular. In vacuolated fibers, no or few deposits positive for p38 or JNK were observed.



View larger version (119K):
[in this window]
[in a new window]
  		Figure 2. Extracellular signal-regulated kinase immunostaining (A, C, E) in vacuolated fibers in inclusion body myositis, and nuclear DNA staining with Hoechst 33258 in the same sections (B, D, F). The bright spots represent nuclei (x680 before reduction).

 
Diffuse moderate ERK, p38, and JNK immunoreactivity was observed in regenerating fibers and in some degenerating fibers.

In vacuolated fibers in IBM, there were strong Elk-1–immunopositive deposits ( figure 3, A, C, and E). Their localization and contours were identical with those of ERK-positive deposits. We confirmed this in a double immunofluorescence study ( figure 4, upper row). We next examined the relationship between the Elk-1–positive deposits and those of SMI-31, a marker of IBM filaments.8 The distribution and configuration of the Elk-1–positive deposits were the same as those of SMI-31 (see figure 4, lower row) in vacuolated fibers. Although SMI-31 also stained axons of IM nerves, as described previously,21 anti–Elk-1 did not.



View larger version (94K):
[in this window]
[in a new window]
  		Figure 3. Elk-1 immunoreactivity (A, C, E) and nuclear staining (B, D, F) in the same sections in vacuolated fibers in inclusion body myositis (x680 before reduction).

 


View larger version (21K):
[in this window]
[in a new window]
  		Figure 4. Two-color immunofluorescence. Localization in the same sections and fibers. Upper row: extracellular signal-regulated kinase (orange) and Elk-1 (green). Lower row: SMI-31 (orange) and Elk-1 (green) (x400).

 
There were no immunoreactive deposits for c-Jun, the nuclear substrate of JNK, in vacuolated fibers in IBM.

Comparison of ERK- or Elk-1–positive deposits with the localization of nuclei in vacuolated fibers in s-IBM. ERK- or Elk-1–positive deposits were often observed on the external surface of the nuclei, but were sometimes also present in the cytoplasm unrelated to the nuclear localization (see figure 2, B, D, and F, and figure 3, B, D, and F). There were sometimes overlaps of the positive deposits and nuclei. In rare fibers, protrusions of the positive deposits into nuclei were observed.

A quantitative study of the relationship between ERK-positive deposits and 275 nuclei in 61 randomly selected and photographed ERK-positive fibers indicated that 78.2% of the nuclei were closely associated with the deposits; 3.2% of the 275 nuclei had ERK-positive deposits occupying more than half of their area, and 75.0% of the nuclei were touched, penetrated, or partially covered by the deposits.

Findings in other vacuolar myopathies. Distal myopathy with rimmed vacuoles. As in s-IBM, strong focal immunoreactivity of ERK and Elk-1, but not of p38, JNK, or c-Jun were observed in vacuolated fibers ( figure 5, A andB). As in s-IBM, 28% of the nuclei in ERK-positive fibers were closely associated with the immunopositive deposits.



View larger version (118K):
[in this window]
[in a new window]
  		Figure 5. Extracellular signal-regulated kinase (ERK) and Elk-1 immunolocalization in control subjects. Positive deposits of (A) ERK and (B) Elk-1 in distal myopathy with rimmed vacuoles. (C) Small circular ERK-positive immunoreactivity in acid maltase deficiency. (D) ERK immunostaining in oculopharyngeal muscular dystrophy; only a small positive dot is observed in the vacuoles. (E) Cytoplasmic ERK-positive deposits in colchicine myopathy. (F) ERK-positive target formations in neurogenic muscular atrophy. (G) ERK and (H) Elk-1 in regenerating fibers in dermatomyositis. Elk-1 shows strong nuclear reactivity (x340 before reduction).

 
Acid maltase deficiency. Immunoreactivity for MAPKs was observed on the boundaries of vacuoles (see figure 5C). Elk-1 and c-Jun were negative.

Oculopharyngeal muscular dystrophy. No ERK-positive dots or few small ERK-positive dots were found in vacuolated fibers (see figure 5D).

Colchicine myopathy. Focal cytoplasmic deposits containing ERK, p38, JNK, Elk-1, and c-Jun were observed in a fraction of vacuolated and nonvacuolated fibers (see figure 5E).

Findings in other control subjects. Specimens without pathologic findings were negative or weakly positive for MAPKs and the transcription factors. No focal deposits were observed. Target formations showed strong activity for MAPKs, Elk-1, and c-Jun (see figure 5F). Regenerating/degenerating fibers showed positive immunoreactivity for MAPKs and Elk-1 (see figure 5, G andH). These fibers were variably positive for c-Jun.


   Discussion.
Top.
 Article Abstract
 Introduction
 Materials and methods.
 Results.
 Discussion.
References
 
Several growth factors and hormones have been shown to be associated with the growth and differentiation of muscle cells.22 However, until recently, little was known about the consequent intracellular mechanisms that finally activate the MyoD family of transcription factors, which regulate differentiation of muscle cells. Recent studies have indicated involvement of MAPKs in the control of the myogenic transcription factors. In a study of C2 muscle cell cultures, ERK was activated during muscle fiber terminal differentiation, and it positively regulated the activity of MyoD, while the high JNK activity of myoblasts was downregulated.14 Also, p38 may play a positive role in muscle fiber differentiation earlier than ERK via another myogenic transactivation factor, MEF2.23 Regenerating fibers consist of replicating myoblasts and differentiating myotubes.17 Thus, the presence of MAPKs in regenerating fibers in diseased muscles may correlate with the findings of the cell culture studies. Because SRF, the partner of activated Elk-1 in the nucleus (see figure 1A), is also essential for muscle fiber differentiation,24 ERK probably takes part in myogenesis via phosphorylation of Elk-1.14

Whereas ERK-positive immunoreactivity was not found in normal fibers and was diffuse in the cytoplasm of regenerating fibers, very strong immunoreactive deposits of ERK were found in vacuolated fibers in IBM. These deposits were round or irregular in shape, and were present in the cytoplasm or in vacuoles. A fraction of the ERK-positive deposits was closely associated with the nuclei of the vacuolated fibers, and was frequently located on the surface of the nuclei. The abnormal cytoplasmic condensation of ERK protein may result from an abnormality of the ERK molecule itself or of another molecule that prevents abnormal aggregation of ERK. Because the nuclear transcription factor Elk-1 showed similar cytoplasmic aggregation and perinuclear localization, we suspect a defect in a chaperone-like molecule involved in the folding and nuclear transport of Elk-1 and ERK.

Both cytoplasmic and nuclear proteins, including Elk-1, are synthesized in the endoplasmic reticulum. Newly synthesized proteins destined for the nucleus or some activated enzymes, such as MAPKs, are transported through the nuclear membrane. This import is a selective and mediated process in which sets of chaperone molecules, vehicle proteins, and energy suppliers take part. Inhibition of any component of the nuclear transport system results in cytoplasmic and perinuclear accumulation of karyophilic proteins.25 For example, heat shock cognate protein 70 (HSC70), which belongs to the family of heat shock proteins, is a carrier protein in nuclear transport. In human cell cultures, cytoplasmic injection of antibodies against HSC70 strongly inhibits the nuclear import of several karyophilic proteins and causes their cytoplasmic aggregation.26 In yeast cells, HOG1 MAPK translocates into the nucleus upon activation. Mutations in transport proteins result in impaired cytonuclear transport and cytoplasmic accumulation of HOG1 MAPK.27 We found cytoplasmic and perinuclear accumulation of ERK in vacuolated fibers of IBM, but not of p38 or JNK, the two kinases which show strong activity in regenerating fibers. ERK is the last MAPK that becomes activated during muscle fiber differentiation.14,23 Therefore, the defect that causes abnormal ERK accumulation may occur in the late phase of differentiation, after JNK and p38 activities have declined. Chaperone proteins or heat shock proteins show regulated expression during differentiation and development28; a chaperone protein that is specifically involved in this phase of differentiation might be responsible for the abnormality in the vacuolated fibers in IBM. The same abnormal mechanism may also cause the perinuclear accumulation of Elk-1.

We showed focal deposits of Elk-1 colocalized with SMI-31 immunoreactivity in vacuolated fibers in IBM. SMI-31 has been developed for phosphorylated epitopes of neurofilament proteins. It can also react with other proteins such as microtubule-associated protein (MAP) tau and MAP-2.29 Because SMI-31 stains IBM filaments,8 ERK and its target Elk-1 may be associated with the filaments or might be components of the filaments. Electron microscopic studies indicated that IBM filaments are largely cytoplasmic, and only occasional nuclei contain those filaments. Rarely, electron micrographs revealed a disruption of nuclear membranes by filamentous inclusions.30 These observations are in accord with the results of the current study of double staining of ERK- or Elk-1–positive deposits and nuclei; in this study, 3.2% of the nuclei in the ERK-positive fibers harbored or were overlaid by immunopositive deposits, and few nuclei were penetrated by the deposits. Conversely, ERK- and Elk-1–positive deposits were often larger than nuclei, and they sometimes occupied almost entire vacuoles. Therefore, these molecules do colocalize with IBM filaments, but they may also be present in other neighboring regions, as has been indicated in SMI-31 immunoreactivity.30

In distal myopathy with rimmed vacuoles, the localization of ERK and Elk-1 was similar to that seen in s-IBM in vacuolated fibers, though the association of ERK-positive deposits with nuclei was weaker than that in s-IBM (28 versus 78%). Nevertheless, a relevant mechanism related to that in s-IBM may operate in this disease and possibly in its allelic disorder, autosomal recessive h-IBM.3,4

Acid maltase deficiency showed immunopositivity for MAPKs on the vacuolar boundaries, but not for their nuclear substrates. The substrates for MAPKs on the boundaries could be cytoskeletal proteins, such as dystrophin, which is present on the vacuolar boundaries31 and can be phosphorylated by MAPKs.32

In vacuolated fibers in OPMD, only a few focal deposits of ERK were observed. Therefore, the mechanism of formation of inclusions in OPMD may be different from that in IBM. In OPMD, a short expansion of triplet repeats in the poly(A) binding protein-2 gene may cause intranuclear accumulation of tubulofilamentous inclusions.33

Colchicine disrupts microtubular networks, thereby preventing intracellular vesicular trafficking.15 Microtubular blocking agents induce stress-activated protein kinases.34 Furthermore, MAPKs and transcription factors are physically associated with microtubules.18,35 Cytoplasmic accumulation of MAPKs and transcription factors in colchicine myopathy may result from a combination of these effects.

Target formations showed the same immunopositivity as colchicine myopathy. This result suggests that MAPKs in the center of the fibers induced by denervation stress are stagnated in the original position. The impairment of molecular trafficking might be more proximal in colchicine myopathy and in target formations than the cytonuclear transport in IBM.

In a previous report, we showed CDK5-positive deposits in vacuolated fibers in IBM. A high proportion of the CDK5-positive deposits abutted on the nucleus, like ERK in the current study.9 CDK5 transiently appears in the nucleus during the terminal differentiation and promotes the process.13 Thus, two protein kinases, both normally activated and translocated into the nucleus during some phase of differentiation, accumulate in the cytoplasm and around the nuclei in vacuolated fibers in IBM. We suspect that the induction of ERK and CDK5 is part of the intrinsic program of muscle fiber differentiation, and that the abnormally high concentration of these enzymes results from their aggregation in the cytoplasm and inability to enter the nucleus. The study of molecules involved in molecular folding36 and nuclear translocation of ERK and CDK5 during differentiation should clarify the molecular mechanism that underlies IBM.

A recent study showed abnormal expression of {alpha}B-crystallin, which belongs to the small heat shock protein family, in IBM.37 Because {alpha}B-crystallin may play a role during myogenesis,38 this molecule might be the defective chaperone protein we postulated above or it might be induced to compensate for the function of another chaperone protein.


   References
Top.
 Article Abstract
 Introduction
 Materials and methods.
 Results.
 Discussion.
 References
 

  1. Griggs RC, Askanas V, DiMauro S, et al. Inclusion body myositis and myopathies. Ann Neurol 1995; 38: 705–713.[Medline]
  2. Mikol J, Engel AG. Inclusion body myositis. In: Engel AG, Franzini–Armstrong C, ed. Myology. 2nd ed. New York, NY: McGraw-Hill, 1994: 1384–1398.
  3. Mitrani–Rosenbaum S, Argov Z, Blumenfeld A, Seidman CE, Seidman JG. Hereditary inclusion body myopathy maps to chromosome 9p1-q1. Hum Mol Genet 1996; 5: 159–163.[Abstract/Free Full Text]
  4. Nonaka I, Murakami N, Suzuki Y, Kawai M. Distal myopathy with rimmed vacuoles. Neuromuscul Disord 1998; 8: 333–337.[Medline]
  5. Askanas V, Engel WK. New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies. Curr Opin Rheumatol 1995; 7: 486–496.[Medline]
  6. Hill C, Treisman R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 1995; 80: 199–211.[Medline]
  7. Hunter T. Protein kinases and phosphatases: the Yin and Yang of protein phosphorylation and signaling. Cell 1995; 80: 225–236.[Medline]
  8. Askanas V, Alvarez RB, Mirabella M, Engel WK. Use of anti-neurofilament antibody to identify paired-helical filaments in inclusion-body myositis. Ann Neurol 1996; 39: 389–391.[Medline]
  9. Nakano S, Akiguchi I, Nakamura S, Satoi H, Kawashima S, Kimura J. Aberrant expression of cyclin-dependent kinase 5 in inclusion body myositis. Neurology 1999; 53: 1671–1676.[Abstract/Free Full Text]
  10. Force T, Bonventre JV. Growth factors and mitogen-activated protein kinases. Hypertension 1998; 31: 152–161.[Abstract/Free Full Text]
  11. Treisman R. Ternary complex factors: growth factor regulated transcriptional activators. Curr Opin Genet Dev 1994; 4: 96–101.[Medline]
  12. Kyriakis J, Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem 1996; 271: 24313–24316.[Free Full Text]
  13. Lazaro J, Kitzmann M, Poul MA, Vandromme M, Lamb NJ, Fernandez A. Cyclin dependent kinase 5, cdk5, is a positive regulator of myogenesis in mouse C2 cells. J Cell Sci 1997; 110: 1251–1260.[Abstract]
  14. Gredinger E, Gerber AN, Tamir Y, Tapscott SJ, Bengal E. Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells. J Biol Chem 1998; 273: 10436–10444.[Abstract/Free Full Text]
  15. Shinde A, Nakano S, Abe M, Kohara N, Akiguchi I, Shibasaki H. Accumulation of microtubule-based motor protein in a patient with colchicine myopathy. Neurology 2000; 55: 1414–1415.[Free Full Text]
  16. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984; 16: 193–208.[Medline]
  17. Banker B, Engel AG. Basic reactions of muscle. In: Engel AG, Franzini–Armstrong C, ed. Myology. 2nd ed. New York, NY: McGraw-Hill, 1994: 832–888.
  18. Reszka A, Seger R, Diltz CD, Krebs EG, Fischer EH. Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc Natl Acad Sci USA 1995; 92: 8881–8885.[Abstract/Free Full Text]
  19. Clerk A, Sugden PH. Cell stress-induced phosphorylation of ATF2 and c-Jun transcription factors in rat ventricular myocytes. Biochem J 1997; 325: 801–810.
  20. Sgambato V, Vanhoutte P, Pages C, et al. In vivo expression and regulation of Elk-1, a target of the extracellular-regulated kinase signaling pathway, in the adult rat brain. J Neurosci 1998; 18: 214–226.[Abstract/Free Full Text]
  21. Mirabella M, Alvarez RB, Bilak B, Engel WK, Askanas V. Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies. J Neuropathol Exp Neurol 1996; 55: 774–786.[Medline]
  22. Olsen EN. Signal transduction pathways that regulate skeletal muscle gene expression. Mol Endocrinol 1993; 7: 1369–1378.[Free Full Text]
  23. Zetser A, Gredinger E, Bengal E. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. J Biol Chem 1999; 274: 5193–5200.[Abstract/Free Full Text]
  24. Soulez M, Rouviere CG, Chafey P, et al. Growth and differentiation of C2 myogenic cells are dependent on serum response factor. Mol Cell Biol 1996; 11: 6065–6074.
  25. Görlich D, Mattaj IW. Nucleocytoplasmic transport. Science 1996; 271: 1513–1518.[Abstract]
  26. Imamoto N, Matsuoka Y, Kurihara T, et al. Antibodies against 70-kD heat shock cognate protein inhibit mediated nuclear import of karyophilic proteins. J Cell Biol 1992; 119: 1047–1061.[Abstract/Free Full Text]
  27. Ferringno P, Psoas F, Koepp D, Saito H, Silver PA. Regulated nucleo/cytoplasmic exchange of HOG1 MAPK requires the importin homologs NMD5 and XPO1. EMBO J 1998; 17: 5606–5614.[Medline]
  28. Heikkila J. Heat shock gene expression and development. II. An overview of mammalian and avian developmental systems. Dev Genet 1993; 14: 87–91.[Medline]
  29. Nukina N, Kosik KS, Selkoe DJ. Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein. Proc Natl Acad Sci USA 1987; 84: 3415–3419.[Abstract/Free Full Text]
  30. Carpenter S. Inclusion body myositis, a review. J Neuropathol Exp Neurol 1996; 55: 1105–1114.[Medline]
  31. De Bleecker JL, Engel AG, Winkelmann JC. Localization of dystrophin and spectrin in vacuolar myopathies. Am J Pathol 1993; 143: 1200–1208.[Abstract]
  32. Shemanko CS, Sanghera JS, Milner RE, Pelech S, Michalak M. Phosphorylation of the carboxyl terminal region of dystrophin by mitogen-activated protein (MAP) kinase. Mol Cell Biochem 1995; 152: 63–70.[Medline]
  33. Brais B, Rouleau GA, Bouchard JP, Fardeau M, Tomé FM. Oculopharyngeal muscular dystrophy. Semin Neurol 1999; 19: 59–66.
  34. Wang T-H, Wang H-S, Ichijo H, Giannakou P, Foster JS, Fojo T, Wimalasena J. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both ras and apoptosis signal-regulating kinase pathways. J Biol Chem 1998; 273: 4928–4936.[Abstract/Free Full Text]
  35. Gundersen GG, Cook TA. Microtubules and signal transduction. Curr Opin Cell Biol 1999; 11: 81–94.[Medline]
  36. Hendrick JP, Hartl FU. The role of molecular chaperones in protein folding. FASEB J 1995; 9: 1559–1569.[Abstract]
  37. Banwell BL, Engel AG. {alpha}B-crystallin immunolocalization yields new insight into inclusion body myositis. Neurology 2000; 54: 1033–1041.[Abstract/Free Full Text]
  38. Benjamin IJ, Shelton J, Garry DJ, Richardson JA. Temporal expression of the small HSP/{alpha}B-crystallin in cardiac and skeletal muscle during mouse development. Dev Dyn 1997; 208: 75–84.[Medline]
Received March 24, 2000. Accepted in final form October 10, 2000.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
E. Corcelle, M. Nebout, S. Bekri, N. Gauthier, P. Hofman, P. Poujeol, P. Fenichel, and B. Mograbi
Disruption of Autophagy at the Maturation Step by the Carcinogen Lindane Is Associated with the Sustained Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Activity.
Cancer Res., July 1, 2006; 66(13): 6861 - 6870.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. Nakano, A. Shinde, H. Ito, H. Ito, and H. Kusaka
Messenger RNA degradation may be inhibited in sporadic inclusion body myositis
Neurology, August 9, 2005; 65(3): 420 - 425.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
J. M. Lang, K. A. Esser, and E. E. Dupont-Versteegden
Altered Activity of Signaling Pathways in Diaphragm and Tibialis Anterior Muscle of Dystrophic Mice
Experimental Biology and Medicine, June 1, 2004; 229(6): 503 - 511.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. Nakano, A. Shinde, H. Ito, H. Ito, and H. Kusaka
MAP kinase phosphatase-1 is induced in abnormal fibers in inclusion body myositis
Neurology, August 12, 2003; 61(3): 322 - 326.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakano, S.
Right arrow Articles by Kimura, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakano, S.
Right arrow Articles by Kimura, J.
Related Collections
Right arrow All Neuromuscular Disease
Right arrow Muscle disease

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS